Cargando…
Blood Transcriptome Profiling in Myasthenia Gravis Patients to Assess Disease Activity: A Pilot RNA-seq Study
Myasthenia gravis (MG) is an antibody-mediated autoimmune disease characterized by exertional weakness. There is no biomarker to reflect disease activity and guide treatment decision. Here, we reported a pilot blood transcriptome study using RNA sequencing (RNA-seq) that identified differences of 5...
Autores principales: | Park, Kee Hong, Jung, Junghee, Lee, Jung-Hee, Hong, Yoon-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Brain and Neural Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766113/ https://www.ncbi.nlm.nih.gov/pubmed/26924932 http://dx.doi.org/10.5607/en.2016.25.1.40 |
Ejemplares similares
-
B Cell Immunophenotyping and Transcriptional Profiles of Memory B Cells in Patients with Myasthenia Gravis
por: Min, Young Gi, et al.
Publicado: (2019) -
Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018) -
Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features
por: Park, Kee Hong, et al.
Publicado: (2018) -
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
por: Kwon, Young Nam, et al.
Publicado: (2022) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)